Showing results (71-80 of 270) with videos related to
Sort By:
Pageof 27
Journal of Thoracic Disease|August 10, 2023
Aumolertinib in NSCLC with leptomeningeal involvement, harbouring concurrent EGFR exon 19 deletion and TP53 comutation: a case reportZhiquan Qin, Hang Zhang, Peiyuan Yan, et al.International Journal of Molecular Sciences|May 13, 2023
Machine Learning Models for the Identification of Prognostic and Predictive Cancer Biomarkers: A Systematic ReviewQasem Al-Tashi, Maliazurina B Saad, Amgad Muneer, et al.Cancers|December 23, 2022
TP53 Co-Mutation Status Association with Clinical Outcomes in Patients with EGFR-Mutant Non-Small Cell Lung CancerXiuning Le, Cliff Molife, Mark S Leusch, et al.Critical Reviews in Oncology/Hematology|December 22, 2023
Clinical evidence and adverse event management update of patients with RET- rearranged advanced non-small-cell lung cancer (NSCLC) treated with pralsetinibGiuseppe Lo Russo, Paolo Bironzo, Chiara Bennati, et al.Therapeutic Advances in Medical Oncology|May 3, 2014
Bone and brain metastasis in lung cancer: recent advances in therapeutic strategiesChiara D'Antonio, Antonio Passaro, Bruno Gori, et al.Journal of Clinical Medicine|April 12, 2025
The Short-Term Impact of Neoadjuvant Chemotherapy on the Outcome of Patients Undergoing Pneumonectomy for Lung Cancer: Is It Acceptable Nowadays?Antonio Mazzella, Sebastiano Maiorca, Giuseppe Nicolosi, et al.Clinical Lung Cancer|March 11, 2022
Safety of MET Tyrosine Kinase Inhibitors in Patients With MET Exon 14 Skipping Non-small Cell Lung Cancer: A Clinical ReviewAlexis Cortot, Xiuning Le, Egbert Smit, et al.Future Oncology (London, England)|March 31, 2023
Plain language summary of the development of tepotinib: a treatment for a subtype of non-small cell lung cancer called MET exon 14 skippingJohn Hallick, Anne-Marie Baird, Gerald Falchook, et al.Translational Lung Cancer Research|March 15, 2021
Delivery of gefitinib with an immunostimulatory nanocarrier improves therapeutic efficacy in lung cancerDingwei Diao, Jianxue Zhai, Jianjun Yang, et al.Archives of Pathology & Laboratory Medicine|March 23, 2018
Acquired Resistance to Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancers: The Role of Next-Generation Sequencing on Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration SamplesElena Guerini-Rocco, Antonio Passaro, Chiara Casadio, et al.Pageof 27